Search research articles
Contact Us
Filters
Showing results (371-380 of 395) with videos related to
Page
of 40
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 14, 2023
Germline <i>EGFR</i> Mutations and Familial Lung Cancer
Geoffrey R Oxnard, Ruthia Chen, Jennifer C Pharr, et al.
Annals of Internal Medicine
|
October 22, 2020
Clinical Endpoints for Evaluating Efficacy in COVID-19 Vaccine Trials
Devan V Mehrotra, Holly E Janes, Thomas R Fleming, et al.
JCO Global Oncology
|
November 4, 2022
IRONMAN: A Novel International Registry of Men With Advanced Prostate Cancer
Lorelei A Mucci, Jacob Vinson, Theresa Gold, et al.
Medrxiv : the Preprint Server for Health Sciences
|
December 18, 2020
Assessing Durability of Vaccine Effect Following Blinded Crossover in COVID-19 Vaccine Efficacy Trials
Dean Follmann, Jonathan Fintzi, Michael P Fay, et al.
The Lancet. Oncology
|
September 24, 2020
Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial
Thomas Powles, Michiel S van der Heijden, Daniel Castellano, et al.
Cancer Immunology Research
|
May 12, 2018
The Clinical Activity of PD-1/PD-L1 Inhibitors in Metastatic Non-Clear Cell Renal Cell Carcinoma
Rana R McKay, Dominick Bossé, Wanling Xie, et al.
Annals of Internal Medicine
|
April 12, 2021
A Deferred-Vaccination Design to Assess Durability of COVID-19 Vaccine Effect After the Placebo Group Is Vaccinated
Dean Follmann, Jonathan Fintzi, Michael P Fay, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 31, 2018
Large-scale Artemisinin-Piperaquine Mass Drug Administration With or Without Primaquine Dramatically Reduces Malaria in a Highly Endemic Region of Africa
Changsheng Deng, Bo Huang, Qi Wang, et al.
Minerva Urology and Nephrology
|
April 23, 2026
Real-world comparison of the effectiveness and safety of immune-based combinations in elderly patients with advanced renal cell carcinoma (ARON-1 study)
Marco Maruzzo, Alexandr Poprach, Sebastiano Buti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 8, 2016
Body Mass Index and Metastatic Renal Cell Carcinoma: Clinical and Biological Correlations
Laurence Albiges, A Ari Hakimi, Wanling Xie, et al.
Page
of 40
Search research articles
Search
Showing results (371-380 of 395) with videos related to
Sort By:
Page
of 40
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 14, 2023
Germline <i>EGFR</i> Mutations and Familial Lung Cancer
Geoffrey R Oxnard, Ruthia Chen, Jennifer C Pharr, et al.
Annals of Internal Medicine
|
October 22, 2020
Clinical Endpoints for Evaluating Efficacy in COVID-19 Vaccine Trials
Devan V Mehrotra, Holly E Janes, Thomas R Fleming, et al.
JCO Global Oncology
|
November 4, 2022
IRONMAN: A Novel International Registry of Men With Advanced Prostate Cancer
Lorelei A Mucci, Jacob Vinson, Theresa Gold, et al.
Medrxiv : the Preprint Server for Health Sciences
|
December 18, 2020
Assessing Durability of Vaccine Effect Following Blinded Crossover in COVID-19 Vaccine Efficacy Trials
Dean Follmann, Jonathan Fintzi, Michael P Fay, et al.
The Lancet. Oncology
|
September 24, 2020
Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial
Thomas Powles, Michiel S van der Heijden, Daniel Castellano, et al.
Cancer Immunology Research
|
May 12, 2018
The Clinical Activity of PD-1/PD-L1 Inhibitors in Metastatic Non-Clear Cell Renal Cell Carcinoma
Rana R McKay, Dominick Bossé, Wanling Xie, et al.
Annals of Internal Medicine
|
April 12, 2021
A Deferred-Vaccination Design to Assess Durability of COVID-19 Vaccine Effect After the Placebo Group Is Vaccinated
Dean Follmann, Jonathan Fintzi, Michael P Fay, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 31, 2018
Large-scale Artemisinin-Piperaquine Mass Drug Administration With or Without Primaquine Dramatically Reduces Malaria in a Highly Endemic Region of Africa
Changsheng Deng, Bo Huang, Qi Wang, et al.
Minerva Urology and Nephrology
|
April 23, 2026
Real-world comparison of the effectiveness and safety of immune-based combinations in elderly patients with advanced renal cell carcinoma (ARON-1 study)
Marco Maruzzo, Alexandr Poprach, Sebastiano Buti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 8, 2016
Body Mass Index and Metastatic Renal Cell Carcinoma: Clinical and Biological Correlations
Laurence Albiges, A Ari Hakimi, Wanling Xie, et al.
Page
of 40